SANJIV HARPAVAT to Time-to-Treatment
This is a "connection" page, showing publications SANJIV HARPAVAT has written about Time-to-Treatment.
Connection Strength
0.180
-
Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements. JAMA. 2020 03 24; 323(12):1141-1150.
Score: 0.154
-
Beyond the Pediatric end-stage liver disease system: solutions for infants with biliary atresia requiring liver transplant. World J Gastroenterol. 2014 Aug 28; 20(32):11062-8.
Score: 0.026